Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression ; volume:8 ; number:1 ; day:4 ; month:5 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (4.5.2018), 1-14, 12.2018
- Urheber
-
Brohée, Laura
- Beteiligte Personen und Organisationen
-
Peulen, Olivier
Nusgens, Betty
Castronovo, Vincent
Thiry, Marc
Colige, Alain C.
Deroanne, Christophe F.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-25340-9
- URN
-
urn:nbn:de:101:1-2018070223055216823259
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Brohée, Laura
- Peulen, Olivier
- Nusgens, Betty
- Castronovo, Vincent
- Thiry, Marc
- Colige, Alain C.
- Deroanne, Christophe F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Albendazole sensitizes cancer cells to ionizing radiation
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
HMGN1 loss sensitizes lung cancer cells to chemotherapy
Letrozole sensitizes breast cancer cells to ionizing radiation
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
Avicequinone B sensitizes anoikis in human lung cancer cells
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
Albendazole sensitizes cancer cells to ionizing radiation
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
HMGN1 loss sensitizes lung cancer cells to chemotherapy
Letrozole sensitizes breast cancer cells to ionizing radiation
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
Avicequinone B sensitizes anoikis in human lung cancer cells
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
Albendazole sensitizes cancer cells to ionizing radiation
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
HMGN1 loss sensitizes lung cancer cells to chemotherapy
Letrozole sensitizes breast cancer cells to ionizing radiation
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
Avicequinone B sensitizes anoikis in human lung cancer cells
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine